Cypress Asset Management’s GSK GSK Stock Holding History

Cypress Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,880	Closed	-$216K	–	181
2017 Q4	$216K	Sell	4,880 -6,032	-55%	-$279K	0.05%	177
2017 Q3	$554K	Sell	10,912 -800	-7%	-$40.6K	0.12%	122
2017 Q2	$631K	Sell	11,712 -440	-4%	-$23.5K	0.13%	121
2017 Q1	$640K	Sell	12,152 -440	-3%	-$22.3K	0.12%	135
2016 Q4	$606K	Sell	12,592 -120	-0.9%	-$5.93K	0.12%	136
2016 Q3	$685K	Sell	12,712 -280	-2%	-$15.4K	0.14%	129
2016 Q2	$704K	Sell	12,992 -51,736	-80%	-$2.73M	0.14%	129
2016 Q1	$3.28M	Sell	64,728 -672	-1%	-$33.5K	0.67%	51
2015 Q4	$3.3M	Sell	65,400 -344	-0.5%	-$17.5K	0.66%	51
2015 Q3	$3.16M	Sell	65,744 -120	-0.2%	-$6.25K	0.66%	52
2015 Q2	$3.43M	Buy	65,864 +984	+2%	+$55.4K	0.64%	53
2015 Q1	$3.74M	Buy	64,880 +60,540	+1,395%	+$3.47M	0.7%	50
2014 Q4	$232K	Buy	4,340 +320	+8%	+$17.9K	0.04%	180
2014 Q3	$231K	Hold	4,020	–	–	0.04%	191
2014 Q2	$269K	Buy	4,020 +120	+3%	+$8.12K	0.05%	184
2014 Q1	$260K	Sell	3,900 -960	-20%	-$64.9K	0.05%	174
2013 Q4	$324K	Sell	4,860 -720	-13%	-$46.7K	0.06%	156
2013 Q3	$350K	Buy	5,580 +80	+1%	+$5.15K	0.06%	148
2013 Q2	$344K	Buy	+5,500	New	+$349K	0.06%	153

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cypress Asset Management's GSK Position: Q1 2018 in Review

Cypress Asset Management sold out of GSK (GSK) in Q1 2018, closing a stake of 4,880 shares — an estimated $216K sold.

Cypress Asset Management first reported a position in GSK in Q2 2013 and held it in 19 quarters. The position peaked at $3.74M in Q1 2015. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

Cypress Asset Management reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
Cypress Asset Management sold 4,880 GSK shares in Q1 2018, an estimated $216K.
Cypress Asset Management first reported a position in GSK in Q2 2013 and held it in 19 quarters.
Cypress Asset Management's GSK position peaked at $3.74M in Q1 2015.
778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Cypress Asset Management's 13F filing for Q1 2018, filed 14 May 2018.